For example, an anti-CD26 monoclonal antibody or CD26 inhibitor treatment was shown to inhibit growth and invasiveness against several tumor types such as renal cell carcinoma and colon cancer [26, 46]. Here, DPP4 is linked to hereditary clear cell renal cell carcinoma.